These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2960031)

  • 1. Protein C and protein S in mild and moderate preeclampsia.
    Hopmeier P; Halbmayer M; Schwarz HP; Heuss F; Fischer M
    Thromb Haemost; 1987 Aug; 58(2):794-5. PubMed ID: 2960031
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinolytic activity and protein C in preeclampsia.
    Aznar J; Gilabert J; Estellés A; España F
    Thromb Haemost; 1986 Jun; 55(3):314-7. PubMed ID: 3092388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histidine-rich glycoprotein (HRG) in uncomplicated pregnancy and mild and moderate preeclampsia.
    Halbmayer WM; Hopmeier P; Feichtinger C; Rubi K; Fischer M
    Thromb Haemost; 1992 May; 67(5):585-6. PubMed ID: 1519219
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombophilic mutations in pre-eclampsia and pregnancy-induced hypertension.
    Omar SZ; Qvist R; Khaing SL; Muniandy S; Bhalla S
    J Obstet Gynaecol Res; 2008 Apr; 34(2):174-8. PubMed ID: 18412778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation inhibitors in preeclamptic pregnant women.
    Osmanağaoğlu MA; Topçuoğlu K; Ozeren M; Bozkaya H
    Arch Gynecol Obstet; 2005 Mar; 271(3):227-30. PubMed ID: 14735372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of the protein C/protein S anticoagulant system, the endothelium and pregnancy.
    Clark P; Greer IA; Walker ID
    Blood Rev; 1999 Sep; 13(3):127-46. PubMed ID: 10527265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal thrombophilia and the risk of recurrence of preeclampsia.
    Facchinetti F; Marozio L; Frusca T; Grandone E; Venturini P; Tiscia GL; Zatti S; Benedetto C
    Am J Obstet Gynecol; 2009 Jan; 200(1):46.e1-5. PubMed ID: 18845284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in protein, lipoproteid, glycoproteid and sialic acid content during normal pregnancy and in late toxemia].
    Sotnikova LG
    Vopr Okhr Materin Det; 1968 Jun; 13(6):57-60. PubMed ID: 5719547
    [No Abstract]   [Full Text] [Related]  

  • 9. Activated protein C resistance in cord blood from healthy and complicated newborns.
    Gursel T; Kocak U; Kaya Z; Bukulmez A; Atalay Y
    J Matern Fetal Neonatal Med; 2007 Nov; 20(11):797-801. PubMed ID: 17853185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum amyloid a protein and C-reactive protein in normal pregnancy and preeclampsia.
    Kristensen K; Wide-Swensson D; Lindstrom V; Schmidt C; Grubb A; Strevens H
    Gynecol Obstet Invest; 2009; 67(4):275-80. PubMed ID: 19390201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid profile in women with preeclampsia: relationship between plasma triglyceride levels and severity of preeclampsia.
    Mikhail MS; Basu J; Palan PR; Furgiuele J; Romney SL; Anyaegbunam A
    J Assoc Acad Minor Phys; 1995; 6(1):43-5. PubMed ID: 7858376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum proteins in hepatosis of pregnancy and pre-eclampsia.
    Ylöstalo P; Järvinen PA; Reinilä M
    Ann Chir Gynaecol Fenn; 1974; 63(1):7-10. PubMed ID: 4208890
    [No Abstract]   [Full Text] [Related]  

  • 13. [C-reactive protein in women with pre-eclampsia].
    Batashki I; Milchev N; Topalovska D; Uchikova E; Mateva N
    Akush Ginekol (Sofiia); 2006; 45 Suppl 1():47-50. PubMed ID: 16673658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of fibrinogen and C-reactive protein with severity of preeclampsia.
    Ustün Y; Engin-Ustün Y; Kamaci M
    Eur J Obstet Gynecol Reprod Biol; 2005 Aug; 121(2):154-8. PubMed ID: 16054955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibin A levels and severity of preeclampsia.
    Phupong V; Paiwattananupant K; Honsawek S
    Arch Gynecol Obstet; 2009 Aug; 280(2):183-6. PubMed ID: 19107499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated protein C for preeclampsia: tailoring the disease to the therapy.
    Lapinsky SE; Mehta S
    Crit Care Med; 2002 Aug; 30(8):1929-30. PubMed ID: 12163831
    [No Abstract]   [Full Text] [Related]  

  • 17. [Vasoactive prostanoids and inhibitors of blood coagulation in pregnancy-induced hypertension].
    Peterseim H; Kemkes-Matthes B
    Zentralbl Gynakol; 1994; 116(6):331-6. PubMed ID: 8048287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in serum adipocyte fatty acid binding protein and retinol binding protein-4 in normal pregnancy and preeclampsia.
    Shangguan X; Liu F; Wang H; He J; Dong M
    Clin Chim Acta; 2009 Sep; 407(1-2):58-61. PubMed ID: 19573524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of elevated serum heat-shock protein 70 concentration with transient hypertension of pregnancy, preeclampsia and superimposed preeclampsia: a case-control study.
    Molvarec A; Prohászka Z; Nagy B; Szalay J; Füst G; Karádi I; Rigó J
    J Hum Hypertens; 2006 Oct; 20(10):780-6. PubMed ID: 16761027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal serum levels of placental protein 5 in complications of late pregnancy.
    Salem HT; Westergaard JG; Hindersson P; Lee JN; Grudzinskas JG; Chard T
    Obstet Gynecol; 1982 Apr; 59(4):467-71. PubMed ID: 7078900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.